Skip to content

Apotheek Tack

Active
Private limited companyfounded 200620 yrs activePapestraat 2, 8880 Ledegem, BelgiumKBO/BCE: BE 0878.923.037
Summary

Apotheek Tack has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €483k and a net result of €65k. Equity is growing by ~10.9% per year across the filed fiscal years. Its solvency ranks better than 59% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
69 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability54▲+4
Solvency71▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 2.1 against 2.05 in 2024; short-term debt: 34.2% and cash: 22.8% of total assets), but 54.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 20 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
45.7%
Return on assets
6.2%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
30 d late
2024
30 d late
2023
30 d late
2022
66 d late
2021
78 d late
2020
88 d late
2019
122 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€483k▲ 0.1%
2024 · €483k
2018: €245k 2019: €291k 2020: €349k 2021: €405k 2022: €482k 2023: €533k 2024: €483k
2018 → 2025
Total assets
€1.06M▼ 7.7%
2024 · €1.15M
2018: €1.12M 2019: €1.05M 2020: €1.05M 2021: €1.04M 2022: €1.04M 2023: €1.07M 2024: €1.15M
2018 → 2025
Net result
€65k▲ 62.9%
2024 · €40k
2018: €-56k 2019: €45k 2020: €58k 2021: €56k 2022: €77k 2023: €51k 2024: €40k
2018 → 2025
Working capital
€398k▼ 5.4%
2024 · €421k
2018: €106k 2019: €202k 2020: €290k 2021: €353k 2022: €420k 2023: €487k 2024: €421k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€405k-€482k▲ 19.0%€533k▲ 10.6%€483k▼ 9.4%€483k▲ 0.1%
Operating result€45k-€71k▲ 55.9%€80k▲ 12.7%€98k▲ 22.4%€120k▲ 22.2%
Net result€56k-€77k▲ 37.2%€51k▼ 33.5%€40k▼ 21.7%€65k▲ 62.9%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2021: €45k€45kNet result 2021: €56k€56kOperating result 2022: €71k€71kNet result 2022: €77k€77kOperating result 2023: €80k€80kNet result 2023: €51k€51kOperating result 2024: €98k€98kNet result 2024: €40k€40kOperating result 2025: €120k€120kNet result 2025: €65k€65k20212022202320242025€0€50k€100kOperating result 2023: €80k€80kNet result 2023: €51k€51kOperating result 2024: €98k€98kNet result 2024: €40k€40kOperating result 2025: €120k€120kNet result 2025: €65k€65k202320242025
The operating result has risen four years in a row; 2025 is 22% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.06M
Fixed assets €298k ▼ 8.1%
Current assets €760k ▼ 7.6%
Equity and liabilities €1.06M
Equity €483k ▲ 0.1%
Debt €575k ▼ 13.4%
Debt's share of the balance-sheet total falls from 57.9% to 54.3%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€146k
2024 · €156k
Cash flow
€92k
2024 · €98k
Current ratio
2.10
2024 · 2.05
Quick ratio
1.30
2024 · 1.35
Debt to equity
1.19
2024 · 1.37
ROE
13.5%
2024 · 8.3%
ROA
6.2%
2024 · 3.5%
Interest coverage
3.30
2024 · 3.26
Debt ≤ 1 year
€362k
2024 · €401k
Debt > 1 year
€209k
2024 · €261k
Income taxes
€19k
2024 · €13k
Staff costs
€109k
2024 · €89k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.15M€1.06M
Fixed assets21/28€325k€298k
Tangible fixed assets22/27€325k€298k
Land and buildings22€294k€275k
Plant, machinery and equipment23€6k€3k
Furniture and vehicles24€24k€20k
Current assets29/58€822k€760k
Stocks and contracts in progress3€281k€290k
Stocks30/36€281k€290k
Amounts receivable within one year40/41€174k€149k
Trade receivables40€147k€135k
Other amounts receivable41€28k€13k
Current investments50/53€75k€75k=
Cash at bank and in hand54/58€285k€241k
Deferred charges and accrued income490/1€7k€5k
Equity and liabilities
Total equity and liabilities10/49€1.15M€1.06M
Equity10/15€483k€483k
Contributions10/11€200k€200k=
Reserves13€283k€283k
Distributable reserves133€283k€283k
Amounts payable17/49€664k€575k
Amounts payable after more than one year17€261k€209k
Financial debts170/4€261k€209k
Amounts payable within one year42/48€401k€362k
Current portion of amounts payable after more than one year42€51k€51k
Trade debts44€219k€109k
Suppliers440/4€219k€109k
Taxes, remuneration and social security45€16k€19k
Remuneration and social security454/9€16k€19k
Other amounts payable47/48€115k€182k
Accrued charges and deferred income492/3€2k€4k
Income statement Code20242025
Remuneration, social security and pensions62€89k€109k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€58k€26k
Other operating charges640/8€3k€4k
Gross operating margin9900€249k€259k
Operating profit (loss)9901€98k€120k
Financial income75/76B€4k€9k
Recurring financial income75€4k€9k
Financial charges65/66B€48k€44k
Recurring financial charges65€48k€44k
Profit (loss) for the period before taxes9903€54k€84k
Income taxes67/77€13k€19k
Profit (loss) for the period9904€40k€65k
Profit (loss) for the period to be appropriated9905€40k€65k
Appropriation of the result
Profit (loss) to be appropriated9906€40k€65k
Transfer from equity791/2€50k-
Transfer to equity691/2-€284
To other reserves6921-€284
Profit to be distributed694/7€90k€65k
Return on contributions (dividend)694€90k€45k
Directors or managers695-€20k
Social balance
Average headcount (FTE)90871.71.6

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
30-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 30 days late
2024
30-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
31-12
Financial Equity above €500kEq €533k ▲10.6%
5 profitable years in a row build equity to €533k.
05-10
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 66 days late
2022
31-12
Financial Highest result since 2018net €77k ▲37.2%
Net result €77k, the highest in the series.
17-10
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 78 days late
2021
27-10
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 88 days late
2020
30-11
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 122 days late
2019
31-12
Financial Back to profitnet €45k
Net result €45k after one loss-making year.
01-10
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 62 days late
2018
24-09
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 55 days late
2017
29-09
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 60 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ledegem · 1 establishment unit since 2006
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Papestraat 28880 Ledegem
Ground area
1,401 m²
Building footprint
354 m²
Volume, LiDAR
256 m³
Parcel 36010C1059/00A000, Flanders · tallest building 3.1 m. Linked by address, not a title deed.
1 establishment unit
Apotheek Tack-Ghesquière BVBA
Papestraat 2, 8880 LedegemWarehousing and support activities for transportation
since 20062.151.521.861
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
36010C1059/00A000 Flanders 1,401 m² 1 · 354 m² 3.1 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Ledegem2.151.521.861
1 permission
Apotheek (LM>3 maand) · since 12-01-2017

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,370 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded26-01-2006
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.